Aspire Biopharma Holdings IncASBP
Price$8.35

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $34.6KTTM through 31 Mar 2026
Net Income -$3.2MTTM through 31 Mar 2026
Free Cash Flow -$3MTTM through 31 Mar 2026

Margins

Current
Gross Margin20.3%
Operating Margin-5,806.0%
Net Margin-11,367.0%

Returns

-83.2%ROE
-45.2%ROA

Balance Sheet Health

Current Ratio3.11x
Net Debt-$5.4Mnet cash position
Cash & Equivalents$5.9M

Quality Metrics

FCF Margin-8,793.3%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Nutraceutical Products$28.4K
View details

Scaling via national distribution and partnerships, including EoS Fitness for the BUZZ BOMB caffeine brand.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.